caffeine has been researched along with Asthma in 68 studies
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effect of a single oral dose of caffeine (5 mg/kg) on FEV1 and bronchial responsiveness to histamine a double blind, placebo controlled study was performed in eight patients with mild stable asthma." | 9.07 | Decrease of histamine induced bronchoconstriction by caffeine in mild asthma. ( Fuller, RW; Henderson, JC; O'Connell, F, 1993) |
| "It was recently reported that caffeine may reduce the clinical symptoms of asthma and may prevent the clinical manifestations of this disease." | 9.06 | Effect of caffeine on histamine bronchoprovocation in asthma. ( Bertolo, L; Cohen, C; Colacone, A; Kreisman, H; Wolkove, N, 1990) |
| "Caffeine has been reported to result in bronchodilation in asthmatic children." | 9.06 | The bronchodilator effect of caffeine in adult asthmatics. ( Bukowskyj, M; Nakatsu, K, 1987) |
| "The potential influence of dietary caffeine on bronchoprovocation challenges with carbachol was examined in 7 patients with asymptomatic asthma." | 9.06 | Effect of dietary caffeine on airway reactivity in asthma. ( Bachofen, H; Crivelli, M; Jost, G; Preisig, R; Wahlländer, A, 1986) |
| "Randomised clinical trials of oral caffeine compared to placebo or coffee compared to decaffeinated coffee in adults with asthma." | 8.86 | Caffeine for asthma. ( Bara, A; Barley, E; Cates, CJ; Welsh, EJ, 2010) |
| "Randomised trials of oral caffeine compared to placebo in adults with asthma." | 8.81 | Caffeine for asthma. ( Bara, AI; Barley, EA, 2001) |
| "Randomised trials of oral caffeine compared to placebo in adults with asthma." | 8.80 | Caffeine for asthma. ( Bara, AI; Barley, EA, 2000) |
| " Multivariable logistic or linear regression was used for the analysis of urinary levels of caffeine or each of its three major metabolites (paraxanthine, theobromine, and theophylline) and current asthma, lung function, and FeNO." | 8.12 | Urinary caffeine and caffeine metabolites, asthma, and lung function in a nationwide study of U.S. adults. ( Celedón, JC; Forno, E; Han, YY, 2022) |
| " Theophylline was significant only when adjustments were made for age, pregnancy, and menopause in contrast to caffeine that was only significant with no adjustments." | 7.67 | Theophylline and fibrocystic breast disease. ( Bullough, B; Hindi-Alexander, MC; London, WM; Middleton, E; Montes, N; Rosner, DH; Zielezny, MA, 1985) |
| "We compared the bronchodilator effects and pharmacokinetics of orally administered caffeine (10 mg per kilogram of body weight) and theophylline (5 mg per kilogram) in a double-blind, single-dose study in asthmatic patients 8 to 18 years of age." | 7.67 | The bronchodilator effects and pharmacokinetics of caffeine in asthma. ( Becker, AB; Gillespie, CA; Simons, FE; Simons, KJ, 1984) |
| "The newborn's potential for xanthine toxic reactions from placental transfer of theophylline or caffeine conversion from theophylline was studied in 12 newborns of asthmatic mothers." | 7.66 | Placental theophylline transfer in pregnant asthmatics. ( Labovitz, E; Spector, S, 1982) |
| " Regression analysis revealed statistically significant dose-response relationships between peak increases in serum caffeine concentrations and increases in FEV1, FEF25-75%, and Gaw/VL from baseline values." | 6.66 | Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. ( Gong, H; Hui, KK; Lee, EY; Simmons, MS; Tashkin, DP, 1986) |
| "Caffeine ingestion has been associated with changes in FE(NO) concentration in adults." | 5.36 | Changes to exhaled nitric oxide in asthmatic children after drinking a caffeine-containing cola drink. ( Abuzayan, I; Paraskavi, U; Turner, SW, 2010) |
| " The effect exhibited a significant dose-response relationship, with the number of cups of coffee consumed per day being inversely related to asthma prevalence." | 5.28 | Caffeine intake and asthma symptoms. ( Schwartz, J; Weiss, ST, 1992) |
| "To assess the effect of a single oral dose of caffeine (5 mg/kg) on FEV1 and bronchial responsiveness to histamine a double blind, placebo controlled study was performed in eight patients with mild stable asthma." | 5.07 | Decrease of histamine induced bronchoconstriction by caffeine in mild asthma. ( Fuller, RW; Henderson, JC; O'Connell, F, 1993) |
| "Caffeine has been reported to result in bronchodilation in asthmatic children." | 5.06 | The bronchodilator effect of caffeine in adult asthmatics. ( Bukowskyj, M; Nakatsu, K, 1987) |
| "It was recently reported that caffeine may reduce the clinical symptoms of asthma and may prevent the clinical manifestations of this disease." | 5.06 | Effect of caffeine on histamine bronchoprovocation in asthma. ( Bertolo, L; Cohen, C; Colacone, A; Kreisman, H; Wolkove, N, 1990) |
| "The effect of caffeine on exercise-induced bronchoconstriction was examined in ten patients with bronchial asthma." | 5.06 | The effect of caffeine on exercise-induced bronchoconstriction. ( Ben Aharon, Y; Kivity, S; Man, A; Topilsky, M, 1990) |
| "The potential influence of dietary caffeine on bronchoprovocation challenges with carbachol was examined in 7 patients with asymptomatic asthma." | 5.06 | Effect of dietary caffeine on airway reactivity in asthma. ( Bachofen, H; Crivelli, M; Jost, G; Preisig, R; Wahlländer, A, 1986) |
| " The benefits of methylxanthine-based therapies in the apnea of prematurity and their translational potential in pediatric affections of the respiratory tract are here presented." | 4.93 | The potential of methylxanthine-based therapies in pediatric respiratory tract diseases. ( Franco, R; Martínez-Pinilla, E; Oñatibia-Astibia, A, 2016) |
| "Randomised clinical trials of oral caffeine compared to placebo or coffee compared to decaffeinated coffee in adults with asthma." | 4.86 | Caffeine for asthma. ( Bara, A; Barley, E; Cates, CJ; Welsh, EJ, 2010) |
| "Randomised trials of oral caffeine compared to placebo in adults with asthma." | 4.81 | Caffeine for asthma. ( Bara, AI; Barley, EA, 2001) |
| "Randomised trials of oral caffeine compared to placebo in adults with asthma." | 4.80 | Caffeine for asthma. ( Bara, AI; Barley, EA, 2000) |
| " Multivariable logistic or linear regression was used for the analysis of urinary levels of caffeine or each of its three major metabolites (paraxanthine, theobromine, and theophylline) and current asthma, lung function, and FeNO." | 4.12 | Urinary caffeine and caffeine metabolites, asthma, and lung function in a nationwide study of U.S. adults. ( Celedón, JC; Forno, E; Han, YY, 2022) |
| "Our previous studies demonstrated that prenatal caffeine exposure (PCE) caused thymopoiesis inhibition, immune disorders, and airway remodeling in offspring, which raises the question of whether PCE is a risk factor for postnatal asthma." | 3.91 | Inhibition of thymocyte autophagy-associated CD4 ( Hou, LF; Liu, HX; Ping, J; Qu, W; Wen, X; Yan, HY; Zhao, WH, 2019) |
| "The subjects were asthma patients who visited the outpatient clinic of Respiratory Medicine, St Luke's International Hospital, between April and October 2003, and were medicated with sustained-release theophylline tablets (Theodur®)." | 3.77 | Usefulness of the simultaneous determination of serum levels of theophylline and its metabolites in patients medicated with theophylline preparation. ( Chohnabayashi, N; Kizu, J; Nasu, H; Nishimura, N; Uchiyama, N; Watanabe, Y, 2011) |
| "An enzyme immunoassay technique (EMIT) for microdeterminations of caffeine was compared with high performance liquid chromatography (HPLC) and evaluated in 113 neonates and young infants, and in 18 asthmatic and 15 epileptic children." | 3.67 | Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring. ( Aranda, JV; Beharry, K; Charest-Boule, L; Johannes, RJ; Rex, J, 1987) |
| "We compared the bronchodilator effects and pharmacokinetics of orally administered caffeine (10 mg per kilogram of body weight) and theophylline (5 mg per kilogram) in a double-blind, single-dose study in asthmatic patients 8 to 18 years of age." | 3.67 | The bronchodilator effects and pharmacokinetics of caffeine in asthma. ( Becker, AB; Gillespie, CA; Simons, FE; Simons, KJ, 1984) |
| " Theophylline was significant only when adjustments were made for age, pregnancy, and menopause in contrast to caffeine that was only significant with no adjustments." | 3.67 | Theophylline and fibrocystic breast disease. ( Bullough, B; Hindi-Alexander, MC; London, WM; Middleton, E; Montes, N; Rosner, DH; Zielezny, MA, 1985) |
| "The newborn's potential for xanthine toxic reactions from placental transfer of theophylline or caffeine conversion from theophylline was studied in 12 newborns of asthmatic mothers." | 3.66 | Placental theophylline transfer in pregnant asthmatics. ( Labovitz, E; Spector, S, 1982) |
| " Regression analysis revealed statistically significant dose-response relationships between peak increases in serum caffeine concentrations and increases in FEV1, FEF25-75%, and Gaw/VL from baseline values." | 2.66 | Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. ( Gong, H; Hui, KK; Lee, EY; Simmons, MS; Tashkin, DP, 1986) |
| "Enprofylline is a more potent smooth muscle relaxant and antiasthmatic drug than theophylline but does not produce, e." | 2.37 | Effects of enprofylline and theophylline may show the role of adenosine. ( Andersson, KE; Kjellin, G; Persson, CG, 1986) |
| "Caffeine ingestion has been associated with changes in FE(NO) concentration in adults." | 1.36 | Changes to exhaled nitric oxide in asthmatic children after drinking a caffeine-containing cola drink. ( Abuzayan, I; Paraskavi, U; Turner, SW, 2010) |
| " The effect exhibited a significant dose-response relationship, with the number of cups of coffee consumed per day being inversely related to asthma prevalence." | 1.28 | Caffeine intake and asthma symptoms. ( Schwartz, J; Weiss, ST, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (64.71) | 18.7374 |
| 1990's | 6 (8.82) | 18.2507 |
| 2000's | 7 (10.29) | 29.6817 |
| 2010's | 9 (13.24) | 24.3611 |
| 2020's | 2 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YY | 1 |
| Forno, E | 1 |
| Celedón, JC | 1 |
| Lin, F | 1 |
| Zhu, Y | 1 |
| Liang, H | 1 |
| Li, D | 1 |
| Jing, D | 1 |
| Liu, H | 1 |
| Pan, P | 1 |
| Zhang, Y | 1 |
| Liu, HX | 1 |
| Yan, HY | 1 |
| Qu, W | 1 |
| Wen, X | 1 |
| Hou, LF | 1 |
| Zhao, WH | 1 |
| Ping, J | 1 |
| Sweeney, D | 1 |
| Hollins, F | 1 |
| Gomez, E | 1 |
| Saunders, R | 1 |
| Challiss, RA | 1 |
| Brightling, CE | 1 |
| Oñatibia-Astibia, A | 1 |
| Martínez-Pinilla, E | 1 |
| Franco, R | 1 |
| Welsh, EJ | 1 |
| Bara, A | 1 |
| Barley, E | 1 |
| Cates, CJ | 1 |
| VanHaitsma, TA | 1 |
| Mickleborough, T | 1 |
| Stager, JM | 1 |
| Koceja, DM | 1 |
| Lindley, MR | 1 |
| Chapman, R | 1 |
| Watanabe, Y | 1 |
| Chohnabayashi, N | 1 |
| Nasu, H | 1 |
| Nishimura, N | 1 |
| Uchiyama, N | 1 |
| Kizu, J | 2 |
| Abuzayan, I | 1 |
| Paraskavi, U | 1 |
| Turner, SW | 2 |
| Yurach, MT | 1 |
| Davis, BE | 1 |
| Cockcroft, DW | 1 |
| Dinh, QT | 1 |
| Bals, R | 1 |
| MARX, W | 1 |
| KROLL, G | 1 |
| VON JAGIC, N | 1 |
| ECKNIGK, R | 2 |
| KRISCH, J | 1 |
| KRISTINSKY, A | 1 |
| FIORE, G | 1 |
| SAUDAN, Y | 1 |
| THURAU, H | 1 |
| SJOGREN, I | 1 |
| FRUHMANN, G | 1 |
| TERPLAN, M | 1 |
| POLOTSKAIA, EL | 1 |
| LEVINA, SI | 1 |
| RODSOLAINEN, II | 1 |
| BUESSOW, H | 1 |
| BOTTKE, H | 1 |
| GUENTHNER, W | 1 |
| Taylor, ES | 1 |
| Smith, AD | 1 |
| Cowan, JO | 1 |
| Herbison, GP | 1 |
| Taylor, DR | 1 |
| Frey, U | 1 |
| Kuehni, C | 1 |
| Roiha, H | 1 |
| Cernelc, M | 1 |
| Reinmann, B | 1 |
| Wildhaber, JH | 1 |
| Hall, GL | 1 |
| Takata, K | 1 |
| Saruwatari, J | 1 |
| Nakada, N | 1 |
| Nakagawa, M | 1 |
| Fukuda, K | 1 |
| Tanaka, F | 1 |
| Takenaka, S | 1 |
| Mihara, S | 1 |
| Marubayashi, T | 1 |
| Nakagawa, K | 1 |
| Daly, JW | 1 |
| Craig, LC | 1 |
| Harbour, PJ | 1 |
| Forbes, SH | 1 |
| Martindale, S | 1 |
| McNeill, G | 1 |
| Seaton, A | 1 |
| Ayres, JG | 1 |
| Devereux, G | 1 |
| Helms, PJ | 1 |
| Dosch, P | 1 |
| Neyraut-Sutterman, MT | 1 |
| Harrison, A | 1 |
| Haley, TJ | 1 |
| Spector, SL | 1 |
| Berdel, D | 1 |
| Heimann, G | 1 |
| Simmons, K | 1 |
| Becker, AB | 1 |
| Simons, KJ | 1 |
| Gillespie, CA | 1 |
| Simons, FE | 1 |
| Rifas, DC | 1 |
| Labovitz, E | 1 |
| Spector, S | 1 |
| Sherin, K | 1 |
| Valia, KH | 1 |
| Hartman, CA | 1 |
| Kucharczyk, N | 1 |
| Sofia, RD | 1 |
| Henderson, JC | 1 |
| O'Connell, F | 1 |
| Fuller, RW | 1 |
| Watanabe, S | 1 |
| Yasuno, N | 1 |
| Arakawa, Y | 1 |
| Uzu, S | 1 |
| Kanda, S | 1 |
| Komoda, F | 1 |
| Iwata, T | 1 |
| Hayakawa, H | 1 |
| Hayakawa, T | 1 |
| Imai, K | 1 |
| Singh, M | 1 |
| Bara, AI | 2 |
| Barley, EA | 2 |
| Schwartz, J | 1 |
| Weiss, ST | 1 |
| Kivity, S | 1 |
| Ben Aharon, Y | 1 |
| Man, A | 1 |
| Topilsky, M | 1 |
| Colacone, A | 1 |
| Bertolo, L | 1 |
| Wolkove, N | 1 |
| Cohen, C | 1 |
| Kreisman, H | 1 |
| Fredholm, BB | 1 |
| Persson, CG | 1 |
| Andersson, KE | 1 |
| Kjellin, G | 1 |
| Bukowskyj, M | 1 |
| Nakatsu, K | 1 |
| Aranda, JV | 1 |
| Beharry, K | 1 |
| Rex, J | 1 |
| Johannes, RJ | 1 |
| Charest-Boule, L | 1 |
| Crivelli, M | 1 |
| Wahlländer, A | 1 |
| Jost, G | 1 |
| Preisig, R | 1 |
| Bachofen, H | 1 |
| Gong, H | 1 |
| Simmons, MS | 1 |
| Tashkin, DP | 1 |
| Hui, KK | 1 |
| Lee, EY | 1 |
| Hindi-Alexander, MC | 1 |
| Zielezny, MA | 1 |
| Montes, N | 1 |
| Bullough, B | 1 |
| Middleton, E | 1 |
| Rosner, DH | 1 |
| London, WM | 1 |
| Harwell, WB | 1 |
| Patterson, JT | 1 |
| Lieberman, P | 1 |
| Beachey, E | 1 |
| Murad, F | 1 |
| Naess, K | 1 |
| Blumstein, CG | 1 |
| Sturm, A | 1 |
| Scheja, HW | 1 |
| Puentes, F | 1 |
| Blamoutier, J | 1 |
| Mot, JC | 1 |
| Travagli, JP | 1 |
| Pasternak, DP | 1 |
| Socolow, EL | 1 |
| Ingbar, SH | 1 |
| Sedivec, V | 1 |
| Krynyckyj, V | 1 |
| Wendt, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Caffeine on Exhaled Nitric Oxide Levels and Methacholine PC20[NCT01057875] | 15 participants (Anticipated) | Interventional | 2010-01-31 | Completed | |||
| Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?[NCT01239199] | 86 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| [NCT00005284] | 0 participants | Observational | 1985-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for caffeine and Asthma
| Article | Year |
|---|---|
The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
Topics: Adolescent; Apnea; Asthma; Bronchodilator Agents; Caffeine; Child; Child, Preschool; Cough; Humans; | 2016 |
Caffeine for asthma.
Topics: Adult; Asthma; Bronchi; Bronchodilator Agents; Caffeine; Humans; Randomized Controlled Trials as Top | 2010 |
Caffeine analogs: biomedical impact.
Topics: Alzheimer Disease; Asthma; Biomedical Research; Caffeine; Calcium; Central Nervous System Stimulants | 2007 |
Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults.
Topics: Adult; Age Factors; Apnea; Asthma; Biotransformation; Bradycardia; Caffeine; Child; Female; Half-Lif | 1983 |
Caffeine for asthma.
Topics: Adult; Asthma; Bronchi; Caffeine; Humans; Respiratory Function Tests | 2000 |
Caffeine for asthma.
Topics: Adult; Asthma; Bronchi; Caffeine; Humans; Randomized Controlled Trials as Topic; Respiratory Functio | 2001 |
Effects of enprofylline and theophylline may show the role of adenosine.
Topics: Adenosine; Animals; Asthma; Brain; Bronchodilator Agents; Caffeine; Diuresis; Fatty Acids, Nonesteri | 1986 |
Clinical studies and applications of cyclic nucleotides.
Topics: Affective Symptoms; Animals; Asthma; Caffeine; Calcitonin; Calcium; Catecholamines; Circadian Rhythm | 1973 |
Drug treatment in bronchial asthma.
Topics: Acetylcysteine; Anti-Bacterial Agents; Asthma; Bronchodilator Agents; Caffeine; Drug Combinations; E | 1973 |
11 trials available for caffeine and Asthma
| Article | Year |
|---|---|
Comparative effects of caffeine and albuterol on the bronchoconstrictor response to exercise in asthmatic athletes.
Topics: Albuterol; Analysis of Variance; Asthma; Bronchoconstriction; Bronchodilator Agents; Caffeine; Centr | 2010 |
The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide.
Topics: Adult; Asthma; Bronchial Provocation Tests; Caffeine; Coffee; Exhalation; Female; Forced Expiratory | 2011 |
[Asthma bronchiale: lung function is affected by coffeine].
Topics: Administration, Oral; Adult; Aged; Asthma; Caffeine; Central Nervous System Stimulants; Female; Huma | 2012 |
Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Anti-Asthmatic Agents; Anti-Inf | 2004 |
[Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].
Topics: Adolescent; Asthma; Bronchitis; Caffeine; Child; Child, Preschool; Chromatography, High Pressure Liq | 1984 |
Decrease of histamine induced bronchoconstriction by caffeine in mild asthma.
Topics: Adult; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Caffeine; Double-Blind Method; Fema | 1993 |
The effect of caffeine on exercise-induced bronchoconstriction.
Topics: Adult; Asthma; Asthma, Exercise-Induced; Bronchi; Bronchodilator Agents; Caffeine; Dose-Response Rel | 1990 |
Effect of caffeine on histamine bronchoprovocation in asthma.
Topics: Asthma; Bronchi; Bronchial Provocation Tests; Caffeine; Double-Blind Method; Female; Forced Expirato | 1990 |
The bronchodilator effect of caffeine in adult asthmatics.
Topics: Adult; Asthma; Bronchodilator Agents; Caffeine; Clinical Trials as Topic; Double-Blind Method; Force | 1987 |
Effect of dietary caffeine on airway reactivity in asthma.
Topics: Administration, Oral; Adult; Airway Resistance; Asthma; Biotransformation; Bronchial Provocation Tes | 1986 |
Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects.
Topics: Administration, Oral; Adult; Aged; Aminophylline; Asthma; Bronchodilator Agents; Caffeine; Coffee; D | 1986 |
48 other studies available for caffeine and Asthma
| Article | Year |
|---|---|
Urinary caffeine and caffeine metabolites, asthma, and lung function in a nationwide study of U.S. adults.
Topics: Adult; Asthma; Bronchodilator Agents; Caffeine; Coffee; Cross-Sectional Studies; Humans; Lung; Nutri | 2022 |
Association of Coffee and Tea Consumption with the Risk of Asthma: A Prospective Cohort Study from the UK Biobank.
Topics: Adult; Aged; Asthma; Biological Specimen Banks; Caffeine; Coffee; Humans; Middle Aged; Prospective S | 2022 |
Inhibition of thymocyte autophagy-associated CD4
Topics: Animals; Asthma; Autophagy; Caffeine; CD4-Positive T-Lymphocytes; Central Nervous System Stimulants; | 2019 |
[Ca2+]i oscillations in ASM: relationship with persistent airflow obstruction in asthma.
Topics: Adult; Aged; Asthma; Biopsy; Caffeine; Calcium Signaling; Case-Control Studies; Female; Forced Expir | 2014 |
Usefulness of the simultaneous determination of serum levels of theophylline and its metabolites in patients medicated with theophylline preparation.
Topics: Asthma; Bronchodilator Agents; Caffeine; Chromatography, High Pressure Liquid; Humans; Smoking; Theo | 2011 |
Changes to exhaled nitric oxide in asthmatic children after drinking a caffeine-containing cola drink.
Topics: Asthma; Caffeine; Carbonated Beverages; Central Nervous System Stimulants; Child; Exhalation; Female | 2010 |
[The treatment of bronchial asthma with A-M 1].
Topics: Alkaloids; Asthma; Atropa belladonna; Caffeine; Calcium; Calcium, Dietary; Ephedrine; Humans; Papave | 1953 |
[Contributions and experiences regarding ambulant asthma-Frenon therapy of resistant asthma attacks].
Topics: Asthma; Caffeine; Cardiovascular Agents; Exercise Therapy; Humans; Muscle Relaxants, Central | 1954 |
[Asthma and emphysema].
Topics: Asthma; Atropine; Caffeine; Emphysema; Epinephrine; Humans; Pulmonary Emphysema | 1956 |
[Treatment of asthma bronchialis].
Topics: Asthma; Caffeine; Calcium; Calcium, Dietary; Humans; Iodides; Iodine; Procaine | 1956 |
[Treatment of asthma bronchialis].
Topics: Asthma; Caffeine; Calcium; Calcium, Dietary; Humans; Iodides; Iodine; Procaine | 1956 |
[Treatment of asthma bronchialis].
Topics: Asthma; Caffeine; Calcium; Calcium, Dietary; Humans; Iodides; Iodine; Procaine | 1956 |
[Treatment of asthma bronchialis].
Topics: Asthma; Caffeine; Calcium; Calcium, Dietary; Humans; Iodides; Iodine; Procaine | 1956 |
[Treatment of tuberculotic asthmatics with neocajod].
Topics: Amino Alcohols; Asthma; Caffeine; Iodides; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Bronchial asthma and therapeutic use of asthmocain].
Topics: Arginine Vasopressin; Asthma; Caffeine; Humans; Procaine; Vasopressins | 1957 |
[Sedative effect of the mixture felsol in the dyspnea of asthmatics & cardiac patients].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Asthma; Caffeine; Cardiac Glycosides; Dyspnea; H | 1958 |
[Treatment of insomnia in asthmatics with hypnasmine].
Topics: Asthma; Barbiturates; Caffeine; Humans; Sleep Initiation and Maintenance Disorders; Theophylline | 1960 |
[Experiences in the treatment of bronchial asthma with Afran].
Topics: Aminopyrine; Asthma; Caffeine; Prednisone | 1962 |
[Theomyl, a new synthetic asthma preparation].
Topics: Albuterol; Asthma; Caffeine; Epinephrine; Ipratropium; Theophylline | 1962 |
[ON THE THERAPY OF BRONCHIAL ASTHMA AND ASTHMATOID BRONCHITIS.SPIROGRAPHIC AND RESPIRATORY FUNCTION STUDIES].
Topics: Antipyrine; Asthma; Bronchitis; Bronchodilator Agents; Caffeine; Humans; Isoproterenol; Respiratory | 1964 |
[ON ISOLATED ALLERGIC MYOCARDITIS].
Topics: Asthma; Bronchitis; Caffeine; Cardiac Complexes, Premature; Drug Therapy; Electrocardiography; Epine | 1964 |
[ON SOME FEATURES OF THE FUNCTIONAL STATE OF THE CENTRAL NERVOUS SYSTEM OF PATIENTS WITH BRONCHIAL ASTHMA].
Topics: Asthma; Caffeine; Central Nervous System; Ephedrine; Humans; Nervous System; Respiratory Function Te | 1964 |
[ON THE PROBLEM OF PSYCHOSES DUE TO ANTIASTHMATIC DRUGS].
Topics: Anti-Asthmatic Agents; Antipyrine; Asthma; Atropine; Caffeine; Digitalis Glycosides; Ephedrine; Hall | 1964 |
[EXPERIMENTAL STUDIES OF AN ASTHMA POWDER IN A DOUBLE BLIND TRIAL].
Topics: Antipyrine; Asthma; Biomedical Research; Bronchodilator Agents; Caffeine; Double-Blind Method; Drug | 1964 |
Maternal atopic disease modifies effects of prenatal risk factors on exhaled nitric oxide in infants.
Topics: Anthropometry; Asthma; Breath Tests; Caffeine; Coffee; Cohort Studies; Environmental Exposure; Fathe | 2004 |
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
Topics: Adult; Aged; Aged, 80 and over; Asthma; Bronchodilator Agents; Caffeine; Cytochrome P-450 CYP1A2; De | 2006 |
Carbonated drink consumption and increased exhaled nitric oxide in atopic children.
Topics: Asthma; Breath Tests; Caffeine; Carbonated Beverages; Child; Exhalation; Humans; Hypersensitivity, I | 2007 |
[Huneke's neural therapy demonstrated on bronchial asthma].
Topics: Adolescent; Adult; Asthma; Caffeine; Female; Humans; Male; Procaine | 1967 |
[EEG studies of cases with epileptic and intricate somatic manifestations].
Topics: Adult; Asthma; Atropa belladonna; Caffeine; Child; Drug Tolerance; Eczema; Electroencephalography; E | 1967 |
Behavioural problems in children taking theophylline.
Topics: Adult; Asthma; Caffeine; Child; Child Behavior Disorders; Depressive Disorder; Female; Humans; Theop | 1984 |
The treatment of the asthmatic mother during pregnancy and lactation.
Topics: Adrenal Cortex Hormones; Asthma; Bronchodilator Agents; Caffeine; Cromolyn Sodium; Ethanol; Female; | 1983 |
Caffeine opens airways for asthmatics.
Topics: Asthma; Bronchi; Bronchodilator Agents; Caffeine; Humans | 1984 |
The bronchodilator effects and pharmacokinetics of caffeine in asthma.
Topics: Adolescent; Asthma; Bronchodilator Agents; Caffeine; Child; Double-Blind Method; Humans; Kinetics; R | 1984 |
Caffeine for bronchial asthma.
Topics: Asthma; Bronchodilator Agents; Caffeine; Humans | 1984 |
Placental theophylline transfer in pregnant asthmatics.
Topics: Adolescent; Adult; Asthma; Caffeine; Female; Fetal Blood; Fetus; Half-Life; Heart; Hemodynamics; Hum | 1982 |
Smoking cessation: the physician's role.
Topics: Asthma; Caffeine; Cerebrovascular Disorders; Coronary Disease; Humans; Male; Motivation; Neoplasms; | 1982 |
Simultaneous determination of dyphylline and theophylline in human plasma by high-performance liquid chromatography.
Topics: Asthma; Caffeine; Chromatography, High Pressure Liquid; Dyphylline; Humans; Reference Values; Theobr | 1980 |
Development and clinical application of high performance liquid chromatography for the simultaneous determination of plasma levels of theophylline and its metabolites without interference from caffeine.
Topics: Adolescent; Adult; Aged; Asthma; Caffeine; Child; Chromatography, High Pressure Liquid; Female; Fluo | 1999 |
Caffeine and asthma.
Topics: Asthma; Caffeine; Humans; Pulmonary Ventilation | 1999 |
Food allergy.
Topics: Adult; Allergens; Animals; Asthma; Caffeine; Cattle; Child; Female; Food Hypersensitivity; Humans; I | 1979 |
Caffeine intake and asthma symptoms.
Topics: Adult; Aged; Asthma; Caffeine; Coffee; Dose-Response Relationship, Drug; Humans; Middle Aged; Odds R | 1992 |
On the mechanism of action of theophylline and caffeine.
Topics: Adenosine; Asthma; Caffeine; Calcium; Cyclic AMP; Humans; Muscle Contraction; Receptors, Cell Surfac | 1985 |
Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring.
Topics: Anticoagulants; Asthma; Caffeine; Chromatography, High Pressure Liquid; Humans; Immunoenzyme Techniq | 1987 |
Theophylline and fibrocystic breast disease.
Topics: Adult; Age Factors; Asthma; Caffeine; Estrogens; Female; Fibrocystic Breast Disease; Humans; Menopau | 1985 |
Platelet aggregation in atopic and normal patients.
Topics: Asthma; Bacterial Proteins; Caffeine; Cyclic AMP; Epinephrine; Humans; Hypersensitivity, Immediate; | 1973 |
[Combinated oral antiasthmatics--how effective are they? An invitation to discussion].
Topics: Administration, Oral; Antipyrine; Asthma; Caffeine; Drug Combinations; Ephedrine; Humans; Parasympat | 1974 |
[Differential diagnosis of increased catecholamine excretion in arterial hypertension].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Arteries; Asthma; Caffeine; Catecholamines; Diagnosis, Diff | 1970 |
[Advantage of a new therapeutic agent for respiratory dyspneic diseases].
Topics: Asthma; Bronchial Diseases; Bronchodilator Agents; Caffeine; Dyspnea; Male; Parasympatholytics; Theo | 1970 |
Synergistic interaction of phenazone and iodide on thyroid hormone biosynthesis in the rat.
Topics: Animals; Antipyrine; Asthma; Caffeine; Chromatography, Paper; Digitalis; Diiodotyrosine; Drug Synerg | 1969 |
[Mental disorders in chronic Yastyl poisoning].
Topics: Adult; Antipyrine; Asthma; Caffeine; Ephedrine; Humans; Male; Middle Aged; Procaine; Psychoses, Subs | 1966 |
[The treatment of bronchial asthma and the combination treatment of acute and chronic bronchial, bronchopulmonary and pulmonary infections with Asthma 23D. An experience report of medical practice during the time period of 5 years].
Topics: Acute Disease; Adult; Aminopyrine; Anti-Bacterial Agents; Antitubercular Agents; Asthma; Atropa bell | 1966 |